Nexalin Share Price
NASDAQ: NXL | Micro Cap | HealthcareNexalin Stock Performance
Nexalin Share Price Chart
Nexalin Quarterly Profit & Loss
All figures in USD
Nexalin Annual Profit & Loss
All figures in USD
Nexalin Balance Sheet
All figures in USD Million
Nexalin Cash Flow
All figures in USD Million
Corporate Actions
About Nexalin
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
Nexalin Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.53 | $1.54 | +1.99% |
Oct 2026 | $8.58 | $1.51 | -71.24% |
Sep 2026 | $5.47 | $5.25 | +1,615.69% |
Aug 2026 | $0.33 | $0.31 | -15.00% |
Jul 2026 | $0.35 | $0.36 | +7.14% |
Jun 2026 | $0.61 | $0.34 | -44.28% |
May 2026 | $0.38 | $0.60 | +74.78% |
Apr 2026 | $0.36 | $0.34 | -1.99% |
Mar 2026 | $0.47 | $0.35 | -25.11% |
Feb 2026 | $0.56 | $0.47 | -16.07% |
Jan 2026 | $0.64 | $0.56 | +0.00% |
Dec 2025 | $0.97 | $0.56 | -48.15% |